This topic contains a solution. Click here to go to the answer

Author Question: The nurse is providing education about pathophysiology and female hormones. The nurse poses this ... (Read 70 times)

ereecah

  • Hero Member
  • *****
  • Posts: 530
The nurse is providing education about pathophysiology and female hormones. The nurse poses this question: Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are products of which structure?
 
  Which response made by one of the students best demonstrates understanding?
  a. Hypothalamus
  b. Anterior pituitary gland
  c. Posterior pituitary gland
  d. Thyroid gland

Question 2

The nurse is talking with a patient about the effectiveness of the medication dose of hormone therapy the patient has been taking. Which of the following would be the best indication that the patient is receiving a sufficient dose of hormone therapy?
 
  a. Reduction in or cessation of hot flashes and night sweats
  b. Increase in urogenital atrophy
  c. Serum lipid profile
  d. Depression screening test



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aliotak

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

ANS: B
FSH and LH are products of the anterior pituitary gland; no further teaching is required.
FSH and LH are not products of the hypothalamus, posterior pituitary gland, or thyroid gland; further teaching is necessary.

Answer to Question 2

ANS: A
The best indication that the patient is receiving a sufficient dose of hormone therapy is a reduction in or cessation of hot flashes and night sweats.
Urogenital atrophy occurs in the absence of estrogen.
Neither a serum lipid profile nor a depression screening test is indicated.





 

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

For a complete list of videos, visit our video library